Why We Resist Taking Breaks. Why is it that we resist taking a break? And are there ways to make breaks a frictionless part ...

Chatbots are far more predictable in their responses than you might expect. That's fine for research or coding, but it's a ...

Every year, bacteria kill more than a million people worldwide through infections that no longer respond to antibiotics. In ...

While there have been many sober warnings about AI and recursive self-improvement, Arianna Huffington argues that it is a ...

Learning to program in C on an online platform can provide structured learning and a certification to show along with your resume. Learning C can still be useful in 2026, especially if you want to ...

And what leaders can do to ease the anxiety. by Erik Hermann, Stefano Puntoni and Carey K. Morewedge As gen AI takes over tasks that were once considered uniquely human, workers are starting to ...

The Insider is a weekly, subscriber-only newsletter, where our managing editor curates HBR stories, research, and ideas that senior leaders shouldn’t miss. Harvard ...

Anthropic published an interesting blog post titled "When AI Builds Itself." a couple of days ago, and if you work in financial services and haven't read it, stop what you're doing. The piece ...

Buy: Anthropic exposure via its likely IPO/secondary path (e.g., IPO allocation or liquid proxy like AI-safety/compute beneficiaries). Rationale: Anthropic is pushing “slow/pause” policy while still ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the Best Penny Stocks with Huge Upside Potential. On May 14, Morgan Stanley raised the price target on Recursion Pharmaceuticals, Inc.